We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Vij - Final Results From the Bortezomib-naïve Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory MM
Ravi Vij, MD
Washington University School of Medicine
Saint Louis, Missouri, USA
12.07.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles